Should the Trials officer / user trial lead bid, partner, acquire, invest or walk away from the opportunity around user trials and acceptance evidence?
Trials often collect data that is not decisive for the acceptance decision.
Answer block
What the page can settle.
Door
Bid / no-bid mini pack
Mapped to the Bid Evidence Pack route.
Buyer
Trials officer / user trial lead
Trials officer or adjacent programme/capability/commercial sponsor
Fit
How Lansary reads it.
DEE structures evidence and uncertainty around user trials and acceptance evidence into decision-ready options.
First step
Bid/no-bid logic, partner map, blockers, evidence confidence
Sell as a board-ready opportunity decision pack.
Start with named public records.
- https://www.gov.uk/government/publications/defence-industrial-strategy-2025-making-defence-an-engine-for-growth
- https://www.war.gov/News/News-Stories/Article/Article/3644527/dod-releases-first-defense-industrial-strategy/
- https://defence-industry-space.ec.europa.eu/eu-defence-industry/edip-forging-europes-defence_en
- https://www.diana.nato.int/
This page is a routing surface. The private Evidence Pack tests the named subject, dates, source boundary and decision consequence.